A nurse is collecting a health history from the guardian of a 4year old child. Which of the following statements by the guardian is the priority for the nurse to address?

A) I will take my inhaler treatment before each meal and at bedtime:
Budesonide is a corticosteroid inhaler used for asthma management, but it is not specifically required to be taken before meals. The timing of inhaler use should be directed by the healthcare provider based on the individual treatment plan. Taking the inhaler at meals is not typically necessary unless specifically instructed, and there is no standard requirement for it to be taken at bedtime either.

B) I will rinse my mouth and gargle with water after each inhaler treatment:
Rinsing the mouth and gargling with water after using an inhaled corticosteroid, like budesonide, is an essential step to reduce the risk of developing oral thrush, a fungal infection. Corticosteroids can promote fungal growth in the mouth, so rinsing helps to clear any residual medication from the mouth and prevent this complication. This statement demonstrates an accurate understanding of the proper use of the inhaler.

C) I should use my inhaler when I have an asthma attack:
Budesonide is a maintenance medication used to control asthma symptoms over the long term, not for immediate relief during an asthma attack. For acute asthma attacks, a fast-acting bronchodilator like albuterol is used, not a corticosteroid like budesonide. The adolescent’s statement reflects a misunderstanding of the purpose of budesonide, which is for prevention and long-term control.

D) I should use my inhaler before exercising:
Using an inhaler before exercise may be appropriate for clients who have exercise-induced bronchoconstriction or asthma, but budesonide is not typically used as a pre-exercise medication. Instead, a short-acting bronchodilator is used before exercise to prevent asthma symptoms during activity. Budesonide is generally used for long-term asthma management rather than for acute symptom relief.

A) "Draw up the insulin lispro and insulin glargine in separate syringes.":
Insulin lispro (a rapid-acting insulin) and insulin glargine (a long-acting insulin) should be administered separately, as they have different properties and mechanisms of action. Mixing them in one syringe can affect their effectiveness and may cause inaccurate dosing. Therefore, the nurse should instruct the client to draw up each insulin in a separate syringe to ensure proper administration and action of both insulins.

B) "Take an extra dose of insulin lispro prior to aerobic exercise.":
Taking an extra dose of insulin lispro before exercise is not recommended unless directed by a healthcare provider. Exercise can lower blood glucose levels, and additional insulin may increase the risk of hypoglycemia. Instead, clients with diabetes are typically advised to monitor their blood glucose levels before and after exercise and adjust their insulin dose or carbohydrate intake accordingly, under the guidance of their healthcare provider.

C) "Expect insulin glargine to be cloudy.":
Insulin glargine is a clear, long-acting insulin. It should not be cloudy. If the insulin appears cloudy, it may be a sign that the insulin has been improperly stored or is no longer effective. The nurse should educate the client to inspect the insulin for cloudiness or particles and to discard any insulin that appears abnormal.

D) "Anticipate that the insulin glargine will peak in 3 hours.":
Insulin glargine is a long-acting insulin that does not have a pronounced peak. It provides a steady release of insulin over 24 hours and helps to maintain baseline insulin levels. It is not meant to peak like rapid-acting or short-acting insulins. Therefore, this instruction is incorrect, as insulin glargine does not follow the same peak-action pattern as other insulins.